Table 1.
Obese Subjects (n = 19) |
Normal-Weight Subjects (n = 14) |
|||||
---|---|---|---|---|---|---|
Parameter | Pre | Post | %Change | Pre | Post | %Change |
Body weight, kg | 94.0 ± 7.4 | 90.3 ± 7.1 | −3.9‡ | 47.4 ± 4.6† | 46.3 ± 4.3 | −2.3 |
BMI, kg/m2 | 33.6 ± 1.9 | 32.3 ± 1.9 | −3.8‡ | 19.9 ± 1.5† | 19.5 ± 1.4 | −2.3* |
BMI, percentile | 95.2 ± 1.4 | 92.5 ± 2.4 | −2.8* | 55.5 ± 7.9† | 51.6 ± 7.4 | −6.9‡ |
WC, cm | 97.2 ± 5.7 | 93.0 ± 4.8 | −4.3‡ | 67.3 ± 5.4† | 64.1 ± 4.0 | −4.8 |
RHR | 95 ± 4 | 80 ± 3 | −15.4‡ | 89 ± 3 | 82 ± 3 | −7.8 |
SBP | 125 ± 4 | 115 ± 2 | −8.1‡ | 106 ± 5† | 105 ± 3 | −1.0 |
DBP | 73 ± 3 | 68 ± 2 | −7.4* | 64 ± 1† | 59 ± 3 | −7.6 |
Glucose, mg/dl | 81.3 ± 2.0 | 85.8 ± 1.3 | 5.5 | 84.7 ± 1.9 | 83.6 ± 2.6 | −1.3 |
Insulin, μU/ml | 22.3 ± 3.5 | 16.1 ± 4.2 | −28.1* | 18.5 ± 4.1 | 8.8 ± 1.3 | −52.5‡ |
HOMA-IR | 4.8 ± 0.8 | 3.4 ± 0.8 | −28.4* | 3.9 ± 0.9 | 1.9 ± 0.3 | −53.1‡ |
QUICKI | 0.31 ± 0.01 | 0.33 ± 0.01 | 4.9‡ | 0.33 ± 0.01 | 0.36 ± 0.01 | 9.3‡ |
TG, mg/dl | 137.7 ± 14.7 | 86.0 ± 7.9 | −37.5‡ | 105.3 ± 19.1 | 62.0 ± 8.1 | −41.1‡ |
Total cholesterol, mg/dl | 166 ± 6.2 | 132.0 ± 5.8 | −20.8‡ | 157.3 ± 9.3 | 120.7 ± 5.1 | −23.3‡ |
LDL cholesterol, mg/dl | 95.0 ± 6.1 | 71.8 ± 5.0 | −24.5‡ | 86.2 ± 8.4 | 60.8 ± 5.9 | −29.4‡ |
HDL cholesterol, mg/dl | 44.0 ± 2.2 | 43.1 ± 2.7 | −2.1 | 50.1 ± 3.6 | 47.5 ± 3.0 | −5.0 |
Total/HDL cholesterol | 4.0 ± 0.3 | 3.3 ± 0.3 | −18.2‡ | 3.3 ± 0.3 | 2.7 ± 0.2 | −19.0‡ |
LDL/HDL | 2.3 ± 0.2 | 1.8 ± 0.2 | −20.7‡ | 1.8 ± 0.2 | 1.4 ± 0.2 | −24.0‡ |
All data are expressed as means ± SE.
Pre, preintervention; post, postintervention; WC, waist circumference; RHR, resting heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostatic model assessment for insulin resistance; QUICKI, quantitative insulin sensitivity check index; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein. Anthropometric and lipid measurements in normal-weight and obese children undergoing a 14-day diet and exercise intervention.
P < 0.05, baseline differences between the normal-weight and obese groups;
P < 0.01;
P < 0.05.